Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), most commonly known as Crohn’s disease (CD) and ulcerative disease (UC), is a chronic and relapsing intestinal disease which cannot be cured completely. The prevalence of IBD in Europe and in North America has increased over the past 20 years. As most IBD patients a...
Main Authors: | Qiyue Wang, Shuyi Mi, Zixuan Yu, Qiyi Li, Jiacai Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/7397523 |
Similar Items
-
Co-pathogens in Periodontitis and Inflammatory Bowel Disease
by: Zhengwen Cai, et al.
Published: (2021-09-01) -
Therapy in inflammatory bowel disease
by: Gustavsson, Anders
Published: (2012) -
Uveitis as an Open Window to Systemic Inflammatory Diseases
by: Thomas El Jammal, et al.
Published: (2021-01-01) -
MSC therapy for inflammatory bowel disease
by: Mikhail A. Konoplyannikov, et al.
Published: (2021-03-01) -
Iron Therapy in Inflammatory Bowel Disease
by: Aditi Kumar, et al.
Published: (2020-11-01)